Zscaler price target raised to $290 from $245 at Evercore ISI
Evercore ISI raised the firm's price target on Zscaler (ZS) to $290 from $245 and keeps an Outperform rating on the shares. Zscaler delivered 'a stellar F3Q,' surpassing expectations across key metrics and reinforcing confidence in the new go-to-market strategy, the analyst tells investors. However, caution is advised as FY26 consensus estimates 'seem overly optimistic for now,' adds the analyst, whose initial FY26 revenue growth estimate is set at 18.5%, below the consensus of 20.2%.
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders' Hot Stocks on TipRanks >>
Read More on ZS:
Disclaimer & DisclosureReport an Issue
Zscaler price target raised to $300 from $270 at TD Cowen
Zscaler price target raised to $290 from $275 at Cantor Fitzgerald
Zscaler price target raised to $300 from $240 at Wedbush
Zscaler price target raised to $304 from $288 at RBC Capital
Zscaler price target raised to $290 from $250 at Oppenheimer
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News24
an hour ago
- News24
Buyers storm SA bond auction —R18bn bids for R4bn issue
Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, and empowerment. You can only trial once.
Yahoo
2 hours ago
- Yahoo
Easterly Government Properties price target lowered to $22 from $27.50 at RBC Capital
RBC Capital analyst Michael Carroll lowered the firm's price target on Easterly Government Properties (DEA) to $22 from $27.50 and keeps an Underperform rating on the shares. The company delivered a largely in-line report after the Board elected to commence a reverse stock split and reduce the dividend, and the firm continues to believe there is some level of uncertainty regarding the current earnings trend with the expected FAA move-out and the US Forest Services downsizing, the analyst tells investors in a research note. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on DEA: Disclaimer & DisclosureReport an Issue Easterly Government Properties Holds Annual Stockholder Meeting Easterly Government Properties Appoints New Accounting Officer Easterly Government Properties Reduces Authorized Shares Easterly Government Properties acquires DHS Law Enforcement Support Center Ex-Dividend Date Nearing for These 10 Stocks – Week of May 5, 2025 Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Forbes
2 hours ago
- Forbes
Amazon, A Small Pharmacy Player, Seeks To Dent CVS And Walgreens Medicare Share
Amazon Pharmacy is rolling out new features in hopes of attracting more seniors covered by Medicare's drug benefit, a potentially lucrative market dominated by CVS Health and Walgreens. In an announcement Tuesday, Amazon said it is launching a new 'caregiver support feature' that allows its customers to have someone else manage medications on their behalf. Once the caregivers are verified through a secure invitation, 'caregivers can now manage medications for their loved ones,' the company said. In addition, customers with Medicare Part D drug coverage can now access PillPack, Amazon's online pharmacy that is designed to simplify medication management, particularly for multiple prescriptions via pre-sorted and labeled packets delivered directly to patients' doors. It's the latest effort by the online retail giant Amazon to invest in its pharmacy business, which Drug Channels Institute estimates generated 'less than $2 billion in 2024 revenue - just 0.3% of the total prescription dispensing market.' Amazon doesn't disclose how many prescriptions it fills or financial information regarding its pharmacy and healthcare businesses. Amazon, which purchased PillPack seven years ago this month for more than $750 million, has yet to disclose revenues for its Amazon Pharmacy business in the parent company's quarterly earnings statements. In contrast, CVS filled 435 million prescriptions in the first quarter for an increase of 4.3% from the year ago period while Walgreens filled more than 309 million prescription in its most recent quarter, up 3.4%. Combined, Walgreens and CVS generated more than $370 billion in prescription revenues last year, According to Dryg Channels. CVS and Walgreens have the largest share of the U.S. prescription market by most measures at a combined 40% while Amazon's share is less than 1%, according to some studies. Neither CVS nor Walgreens would disclose how many Medicare Part D prescriptions the companies fill. By adding features for seniors, Amazon Pharmacy is looking to tap a Medicare prescription market growing by thousands every day. More than 11,000 Americans are turning 65 every day. Amazon is also trying to find a niche with Americans who are caring for an elderly family member. More than 50 million people in the U.S. 'are taking care of an aging family member,' Amazon said citing data from AARP. The aging population, coupled by industry statistics showing up to one-third of Americans don't take their medications as directed or never fill them. 'These updates deliver what our customers have been asking for—simpler medication management for themselves and their loved ones,' Amazon Pharmacy vice president John Love said. 'Whether you're a caregiver juggling multiple prescriptions for an aging parent, or a customer who could benefit from the convenience of pre-sorted packets delivered reliably each month, we're removing barriers and making pharmacy work better for you.'
